Bayer settles more Baycol cases

07 July 2003 00:00  [Source: ICB]

Bayer has now reported it has settled 1042 lawsuits out of court related to its recalled anti-cholesterol drug Baycol.

Earlier this month, the number of out of court settlements was given as 888. The balance of cases pending has remained at 9400 over the past month as some cases were settled and new lawsuits filed.

To date, Bayer has confirmed spending $343m to settle Baycol-related suits.

The drug, recalled in August 2001, has been linked to some 100 deaths, most of them attributed to the severe muscle weakness rhabdomyolysis. Baycol was marketed outside the US under the name Lipobay.

< previous article(VIDEO – ICIS news Americas Lunchtime Bulletin 18 January 2010)

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly